<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Childs Nerv Syst</journal-id>
      <journal-id journal-id-type="iso-abbrev">Childs Nerv Syst</journal-id>
      <journal-title-group>
        <journal-title>Child's Nervous System</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0256-7040</issn>
      <issn pub-type="epub">1433-0350</issn>
      <publisher>
        <publisher-name>Springer Berlin Heidelberg</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26047947</article-id>
      <article-id pub-id-type="pmc">4560763</article-id>
      <article-id pub-id-type="publisher-id">2766</article-id>
      <article-id pub-id-type="doi">10.1007/s00381-015-2766-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Posterior fossa ependymoma in childhood: 60&#xA0;years event-free survival after partial resection&#x2014;a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5772-8965</contrib-id>
          <name>
            <surname>Lundar</surname>
            <given-names>Tryggve</given-names>
          </name>
          <address>
            <phone>+4723074301</phone>
            <email>tryggve.lundar@ous-hf.no</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Due-T&#xF8;nnessen</surname>
            <given-names>Bernt Johan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Krossnes</surname>
            <given-names>B&#xE5;rd</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Due-T&#xF8;nnessen</surname>
            <given-names>Paulina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brandal</surname>
            <given-names>Petter</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Neurosurgery, Oslo University Hospital, Postboks 4950 Nydalen, 0424 Oslo, Norway </aff>
        <aff id="Aff2"><label/>Department of Pathology, Oslo University Hospital, Oslo, Norway </aff>
        <aff id="Aff3"><label/>Department of Oncology, Oslo University Hospital, Oslo, Norway </aff>
        <aff id="Aff4"><label/>Department of Radiology, Oslo University Hospital, Oslo, Norway </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>6</day>
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2015</year>
      </pub-date>
      <volume>31</volume>
      <issue>9</issue>
      <fpage>1573</fpage>
      <lpage>1576</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>10</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>5</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>A 13-year-old boy with severe clinical symptoms and signs underwent surgery for a posterior fossa ependymoma in 1954. The tumor was adjacent to the floor of the fourth ventricle, and surgery was complicated by profound bleeding. Therefore, only a partial resection was performed. Postoperative radiotherapy was given to the posterior fossa. The recovery was uneventful, and he has been in full-time work until the age of 62&#xA0;years and is now 74&#xA0;years old. Repeated MRI scans demonstrate a stable residual fourth ventricular tumor.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Posterior fossa ependymoma</kwd>
        <kwd>Partial resection</kwd>
        <kwd>Pediatric neurosurgery</kwd>
        <kwd>Very long-term follow-up</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag Berlin Heidelberg 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="intro">
      <title>Introduction</title>
      <p>Ependymoma is the third most common posterior fossa tumor in childhood after astrocytoma and medulloblastoma/PNET [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. A spinal primary location is exceedingly rare in children, as opposed to adults, where a spinal presentation is the most common of all ependymoma locations [<xref ref-type="bibr" rid="CR5">5</xref>]. Although there is anecdotal evidence that some patients can be successfully treated with surgery only following gross total resection (GTR), the role of postoperative radiation has clearly been established in retrospective studies and prospective protocols. As a consequence, the current management of intracranial ependymomas is based on maximal surgery followed by conformal radiation to the tumor bed. So far, the role of chemotherapy has not been established [<xref ref-type="bibr" rid="CR3">3</xref>]. The importance of complete tumor resection in ependymoma is critical. Several series have documented the negative impact of incomplete resection on survival. Despite the use of radiation, the outcome of these patients with residual tumor is dismal and the current recommendation is to consider repeat resection when residual tumor is present on postoperative imaging prior to initiation of radiation treatment. Although incomplete resection in patients with posterior fossa ependymoma usually anticipates a negative outcome, there may be some exceptions to this rule, as illustrated in the following case report.</p>
    </sec>
    <sec id="Sec2">
      <title>Case report</title>
      <p>In September 1954, a 13-year-old boy was referred to our department with vertigo, episodes of unclear vision, and later on, vomiting and headache. Clinical investigation revealed choked disks with hemorrhages, nystagmus, a slight right-sided facial paresis, dysdiadochokinesis, and spasticity in the right arm as well as a positive Babinski sign on the left side.</p>
      <p>Ventriculography demonstrated an enlarged supratentorial ventricular system and a tumor in the fourth ventricle. The patient had surgery where a partial occipital bone resection was performed with opening of the foramen magnum and laminectomy of atlas. The dura was pulseless, but after removal of 60&#xA0;cm<sup>3</sup> CSF from the lateral ventricle, the intradural pressure was normalized. After dural incision, a red-brown tumor was exposed medially in the right cerebellar hemisphere and into the fourth ventricle. The tumor was resected, but only partially removed because it was adjacent to the floor of the fourth ventricle, and surgery was complicated by the occurrence of profound bleeding. Microscopic examination revealed a well-circumscribed, moderately cellular glial tumor with several pseudorosettes. No mitoses, microvascular proliferation, or necrosis was found. The tumor cells were positive for glial fibrillary acid protein (GFAP) and negative for epithelial membrane antigen (EMA), synaptophysin, neurofilament protein, and the IDH-1 (R132H mutation). Less than 5&#xA0;% of the tumor cells were Ki-67 positive. The tumor was classified as an ependymoma, WHO grade II.</p>
      <p>Postoperatively, the boy recovered clinically within weeks and the choked disks resolved completely. During the next 2&#xA0;months, he was given high-voltage radiotherapy to the posterior fossa (45&#xA0;Gy in 30 fractions).</p>
      <p>Later on, he returned to school and finished a year later than his peers. He married and got two children. After 26&#xA0;years as a bank officer, the started his own accountant firm.</p>
      <p>He worked full time until the age of 62. At the age of 67, he experienced an episode of syncope but recovered completely without treatment. An MRI demonstrated a large contrast-enhancing tumor of the fourth ventricle. His clinical situation has been stable and good, and the MRI findings are also unchanged after several years of observation (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>MRI of the posterior fossa discloses contrast-enhancing tumor in the fourth ventricle. The situation has been stable for several years, and the patient is without clinical symptoms and signs</p></caption><graphic xlink:href="381_2015_2766_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>Long-term survival after operation for posterior fossa ependymoma in childhood has been observed for many years, especially after GTR [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR7">7</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Tumor free survival has even been observed after repeat surgery due to recurrence [<xref ref-type="bibr" rid="CR11">11</xref>]. Because of the high risk of tumor recurrence, postoperative radiotherapy has been implemented to the posterior fossa and, in earlier years also, to the craniospinal axis. The latter has been abandoned because local control seems to be the key to cure [<xref ref-type="bibr" rid="CR6">6</xref>]. Due to the harmful effects of CNS radiation in small children, such treatment has often been postponed under the age of 3&#xA0;years and, in some centers, below the age of 5&#xA0;years [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
      <p>In small children, chemotherapy has been given as a substitute, but the benefit remains uncertain.</p>
      <p>The present case demonstrates that a very good clinical result may follow after initial surgery, even when incomplete, when followed by local radiation. This is in contrast to our previous experience, and such a good result is not to be expected. The original pathology has been reviewed and confirms the diagnosis of an ependymoma, WHO grade II (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Pathological features of the tumor. A glial tumor with pseudorosettes was seen (<bold>a</bold>, <bold>b</bold>). The tumor cells were positive for GFAP (<bold>c</bold>). Less than 5&#xA0;% of the tumor cells were Ki-67 positive (<bold>d</bold>)</p></caption><graphic xlink:href="381_2015_2766_Fig2_HTML" id="MO2"/></fig></p>
      <p>This now 74-year-old man has no clinical symptoms from the posterior fossa, and 3 different MRI studies have not demonstrated any progression with respect to his residual tumor during a 4-year period. The first MRI was taken after an episode of syncope, 54&#xA0;years after primary treatment. Most probably, his residual tumor has been present ever since the operation in 1954. The situation therefore seems stable and resembles the puzzling situation we have observed in a small group of pediatric patients with recurrent disease decades after primary treatment for distal spinal ependymoma [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>In 2011, Witt and colleagues described two clinically and molecularly distinct subgroups of posterior fossa ependymoma [<xref ref-type="bibr" rid="CR12">12</xref>]. Group A patients, with a more serious prognosis, had lower age and lateral tumor position in the posterior fossa, while group B patients were older with midline tumors. Our patient, therefore, very likely could represent a group B ependymoma with an indolent behavior.</p>
      <p>The present case is also in accordance with the statement made by van Veelen-Vincent and colleagues, &#x201C;The risk of recurrence or progression becomes quite small once the first 5&#xA0;years after the initial surgery have passed uneventfully, regardless of whether initial surgery was complete or incomplete or whether the patient received radio- or chemotherapy&#x201D; [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
      <p>Many children who survive treatment for a posterior fossa ependymoma are left with permanent neurological sequelae after aggressive surgical resection and may furthermore suffer from long-term consequences of radio- or chemotherapy [<xref ref-type="bibr" rid="CR10">10</xref>]. The quality of life for long-term survivors is a challenging and important topic that is sometimes underreported when compared to survival results. In the patient reported here, the surgical resection was only partial due to tumor infiltration in the floor of the fourth ventricle as well as intraoperative hemorrhage, and radiotherapy to the posterior fossa was administered.</p>
      <p>Although the prognosis was considered dubious, the boy recovered completely. It is therefore important to notice that a remarkably good result may occur even for a very long time even if a GTR is not achieved.</p>
    </sec>
  </body>
  <back>
    <ack>
      <sec id="FPar1">
        <title>Conflict of interest</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar2">
        <title>Authors contributions</title>
        <p>All authors have contributed in drafting the manuscript.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cage</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Aranda</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Parsa</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Auguste</surname>
              <given-names>KI</given-names>
            </name>
          </person-group>
          <article-title>A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas. A review</article-title>
          <source>J Neurosurg Pediatr</source>
          <year>2013</year>
          <volume>11</volume>
          <fpage>673</fpage>
          <lpage>681</lpage>
          <pub-id pub-id-type="doi">10.3171/2013.2.PEDS12345</pub-id>
          <pub-id pub-id-type="pmid">23540528</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conter</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Carrie</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bernier</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Geoffray</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pagnier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gentet</surname>
              <given-names>J-C</given-names>
            </name>
            <name>
              <surname>Lellouch-Tubiana</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chabaud</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Frappaz</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Intracranial ependymomas in children: society of pediatric oncology experience with postoperative hyperfractionated local radiotherapy</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2009</year>
          <volume>74</volume>
          <fpage>1536</fpage>
          <lpage>1542</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijrobp.2008.09.051</pub-id>
          <pub-id pub-id-type="pmid">19362789</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duffner</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Horowitz</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Krischer</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Burger</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Sanford</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Mulhern</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Freeman</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Seidel</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Kun</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>Postoperative chemotherapy and delayed radiation on children less than 3&#xA0;years of age with malignant brain tumors</article-title>
          <source>N Engl J Med</source>
          <year>1993</year>
          <volume>328</volume>
          <fpage>1725</fpage>
          <lpage>1731</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199306173282401</pub-id>
          <pub-id pub-id-type="pmid">8388548</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krieger</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Bowen</surname>
              <given-names>IE</given-names>
            </name>
          </person-group>
          <article-title>Effects of surgical resection and adjuvant therapy on pediatric intracranial ependymomas</article-title>
          <source>Expert Rev Neurother</source>
          <year>2005</year>
          <volume>5</volume>
          <fpage>465</fpage>
          <lpage>471</lpage>
          <pub-id pub-id-type="doi">10.1586/14737175.5.4.465</pub-id>
          <pub-id pub-id-type="pmid">16026230</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lundar</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Due-T&#xF8;nnessen</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Scheie</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Brandal</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Pediatric spinal ependymomas: an unpredictable and puzzling disease. Long-term follow-up of a single consecutive institutional series of ten patients</article-title>
          <source>Childs Nerv Syst</source>
          <year>2014</year>
          <volume>30</volume>
          <fpage>2083</fpage>
          <lpage>2088</lpage>
          <pub-id pub-id-type="doi">10.1007/s00381-014-2491-7</pub-id>
          <pub-id pub-id-type="pmid">25079883</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merchant</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Chenghong</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Kun</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Boop</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Sanford</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>A prospective study of conformal radiation therapy for pediatric ependymoma</article-title>
          <source>Lancet Oncol</source>
          <year>2009</year>
          <volume>10</volume>
          <issue>3</issue>
          <fpage>258</fpage>
          <lpage>266</lpage>
          <pub-id pub-id-type="doi">10.1016/S1470-2045(08)70342-5</pub-id>
          <pub-id pub-id-type="pmid">19274783</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M&#xF8;rk</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>L&#xF8;ken</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Ependymoma. A follow-up study of 101 cases</article-title>
          <source>Cancer</source>
          <year>1977</year>
          <volume>40</volume>
          <fpage>907</fpage>
          <lpage>915</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(197708)40:2&lt;907::AID-CNCR2820400247&gt;3.0.CO;2-2</pub-id>
          <pub-id pub-id-type="pmid">890671</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perilongo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Massimino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sotti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Belfontali</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Masiero</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rigobello</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Garr&#xE8;</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian pediatric neuro-oncology group</article-title>
          <source>Med Pediatr Oncol</source>
          <year>1997</year>
          <volume>29</volume>
          <fpage>79</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1096-911X(199708)29:2&lt;79::AID-MPO3&gt;3.0.CO;2-O</pub-id>
          <pub-id pub-id-type="pmid">9180907</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Veelen-Vincent</surname>
              <given-names>MLC</given-names>
            </name>
            <name>
              <surname>Pierre-Kahn</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kalifa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sainte-Rose</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zerah</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Thorne</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Renier</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy</article-title>
          <source>J Neurosurg</source>
          <year>2002</year>
          <volume>97</volume>
          <fpage>827</fpage>
          <lpage>835</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2002.97.4.0827</pub-id>
          <pub-id pub-id-type="pmid">12405370</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vinchon</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Broncini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leblond</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Delestret</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Morbidity and tumor-related mortality among survivors of pediatric brain tumors: a review</article-title>
          <source>Childs Nerv Syst</source>
          <year>2011</year>
          <volume>27</volume>
          <fpage>697</fpage>
          <lpage>704</lpage>
          <pub-id pub-id-type="doi">10.1007/s00381-010-1385-6</pub-id>
          <pub-id pub-id-type="pmid">21409425</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vinchon</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leblond</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Noudel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dhellemmes</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Intracranial ependymomas in childhood: recurrence, reoperation, and outcome</article-title>
          <source>Childs Nerv Syst</source>
          <year>2005</year>
          <volume>21</volume>
          <fpage>221</fpage>
          <lpage>226</lpage>
          <pub-id pub-id-type="doi">10.1007/s00381-004-1070-8</pub-id>
          <pub-id pub-id-type="pmid">15599561</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Witt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mack</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Ryzhova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bender</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sill</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Isserlin</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Delineation of two clinically distinct subgroups of posterior fossa ependymoma</article-title>
          <source>Cancer Cell</source>
          <year>2011</year>
          <volume>20</volume>
          <issue>2</issue>
          <fpage>143</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ccr.2011.07.007</pub-id>
          <pub-id pub-id-type="pmid">21840481</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
